1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,790 | 0,810 | 08:28 | |
| 0,794 | 0,804 | 08:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | CIRCIO HOLDING ASA: Circio selected to deliver oral presentation at the prestigious ESGCT annual meeting | 1 | Oslo Børs | ||
| Di | CIRCIO HOLDING ASA: Circio nominates RNA and gene therapy US industry veteran Dr. Dinah Sah to its Board of Directors | 1 | Oslo Børs | ||
| Di | Circio Holding ASA Notice of extraordinary general meeting on 25 August 2026 | 1 | Oslo Børs | ||
| 16.07. | Circio, Avenue Biosciences Partner on Gene Therapy Protein Expression | 2 | Contract Pharma | ||
| 16.07. | CIRCIO HOLDING ASA: Circio and Avenue Biosciences jointly announce research collaboration to enhance protein secretion for gene therapy | 3 | Oslo Børs | ||
| 24.06. | Circio, Tcelltech Enter CAR-T Cell Therapy Research Collaboration | 1 | Contract Pharma | ||
| 24.06. | Circio Holding ASA: Circio and Tcelltech jointly announce CAR-T cell therapy research collaboration | 1 | Oslo Børs | ||
| CIRCIO Aktie jetzt für 0€ handeln | |||||
| 22.06. | Circio Holding ASA Share capital increase registered | 3 | Oslo Børs | ||
| 18.06. | CIRCIO HOLDING ASA SHARE CAPITAL INCREASE REGISTERED FOLLOWING EXERCISE OF WARRANTS AND UNDERWRITTEN PRIVATE PLACEMENT | 1 | Oslo Børs | ||
| 09.06. | Circio Holding ASA: Last day of the exercise period for the Warrants | 6 | Oslo Børs | ||
| 03.06. | Circio Holding ASA: Last day of trading in warrants | 14 | Oslo Børs | ||
| 01.06. | Circio, GenAssist Partner on AAV Gene Therapy | 4 | Contract Pharma | ||
| 01.06. | Circio Holding ASA: Circio and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy | 2 | Oslo Børs | ||
| 29.05. | Circio Holding ASA Exercise of Warrants by primary insiders | 1 | Oslo Børs | ||
| 28.05. | Circio Holding ASA: Circio hosts live webcast today 28 May 2026 at 10:00 am CEST | 1 | Oslo Børs | ||
| 27.05. | Circio, AaviGen Launch Heart Gene Therapy Collaboration | 2 | Contract Pharma | ||
| 27.05. | Circio Holding ASA: Circio and AaviGen jointly announce research collaboration to advance novel gene therapies for heart diseases | 3 | Oslo Børs | ||
| 26.05. | Circio Holding ASA: Commencement of exercise period for the Warrants | 1 | Oslo Børs | ||
| 26.05. | Circio Holding ASA: Warrants exercise period commences today potential proceeds to transform Circio into a clinical-stage circular RNA company | 5 | Oslo Børs | ||
| 26.05. | Circio Holding ASA: Announcement of the terms of the underwriting and the Unused Warrants Option Agreement in connection with the Warrant Program | 1 | Oslo Børs |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 3,464 | +0,93 % | Übernahmekandidaten! Steyr Motors nach 20 %-Sprung! RE Royalties spannend! Und was macht Evotec? | Um 20 % ist die Aktie von Steyr Motors in der vergangenen Woche kurzzeitig explodiert. Grund waren Übernahmespekulationen durch einen Drohnen- und Robotikspezialisten aus den USA. Die Gespräche wurden... ► Artikel lesen | |
| BB BIOTECH | 55,70 | +1,27 % | Edison Investment Research Limited: Edison issues report on BB Biotech (BION) | Edison Investment Research Limited
Edison issues report on BB Biotech (BION) 28-Jul-2026 / 14:20 GMT/BST
The issuer is solely responsible for the content of this announcement.
... ► Artikel lesen | |
| MEDIGENE | 0,008 | +11,11 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.06.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 30.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.06.2026ISIN NameBE0003593044 COFINIMMOCA8765111064 TASEKO... ► Artikel lesen | |
| MODERNA | 52,50 | +2,60 % | Moderna startet Phase-1-Studie mit Ebola-Impfstoffkandidat | Moderna hat eine Phase-1-Studie mit seinem Impfstoffkandidaten mRNA-1469 gegen das Bundibugyo-Ebolavirus (BDBV) begonnen. Nach der Genehmigung durch die kanadische Gesundheitsbehörde wurden in Kanada... ► Artikel lesen | |
| VALNEVA | 2,303 | +0,57 % | Valnevas Zukunft: Wie Impfstoffkandidaten das Unternehmen prägen könnten | ||
| NOVAVAX | 6,880 | +0,15 % | Novavax, Inc.: Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights | Reported total revenue of $57 million for the second quarter of 2026 and raised full-year 2026 Revenue Framework
Improved GAAP Combined R&D and SG&A expense... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 46,525 | +0,53 % | CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results | ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected... ► Artikel lesen | |
| NANOREPRO | 1,975 | -0,25 % | EQS-DD: NanoRepro AG: Dr. Olaf Stiller, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
03.08.2026 / 07:15... ► Artikel lesen | |
| AAP IMPLANTATE | 1,650 | +4,43 % | EQS-HV: aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: aap Implantate AG
/ Bekanntmachung der Einberufung zur Hauptversammlung
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Berlin... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 0,586 | +2,09 % | Inovio Pharmaceuticals, Inc.: INOVIO Announces Pricing of $20.0 Million Public Offering | PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing... ► Artikel lesen | |
| INFLARX | 1,553 | -2,69 % | InflaRx N.V.: InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones | Announced advancement of izicopan in ANCA-associated vasculitis (AAV) and select renal diseases; clinical preparations ongoing as plannedInitiated feasibility assessment for broadened strategy for... ► Artikel lesen | |
| BAVARIAN NORDIC | 23,600 | 0,00 % | Bavarian Nordic A/S: Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years | MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virusApproval further strengthens MVA-BN's position in... ► Artikel lesen | |
| TEMPUS AI | 45,240 | +0,43 % | BTIG cuts Tempus AI stock price target to $70 on model update | ||
| EDITAS MEDICINE | 2,550 | +2,41 % | Editas Medicine, Inc.: Editas Medicine Announces Second Quarter 2026 Results and Business Updates | EDIT-401 on track for CTN submission this month with data update in Q1 2027 Recently presented pre-clinical data demonstrating ~90% or greater mean reduction in multiple atherogenic lipoproteins,... ► Artikel lesen | |
| BIOMARIN PHARMACEUTICAL | 55,00 | -0,29 % | BioMarin Pharmaceutical Inc.: BioMarin Reports Second Quarter 2026 Financial and Operating Results | Second Quarter 2026 Total Revenues Increased 20% Year-over-year to $990 million
Stronger Growth Expectations Drive Increased Guidance for Full-year 2026 Total Revenues... ► Artikel lesen |
Das Unternehmen CIRCIO HOLDING ASA kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,90 % bei einem Aktienkurs von 0,789 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIRCIO HOLDING ASA finden Sie auf Wallstreet Online.